Related Experiment Videos
Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)
Neurology
|November 1, 1983
Summary
A new Expanded Disability Status Scale (EDSS) refines neurologic impairment assessment in Multiple Sclerosis (MS) by dividing existing steps and revising functional systems. This enhances the precision of the Disability Status Scale for MS patients.
Area of Science:
- Neurology
- Clinical Assessment
- Multiple Sclerosis Research
Background:
- Traditional evaluation of neurologic impairment in Multiple Sclerosis (MS) utilized an 8-Functional System (FS) grading combined with a Disability Status Scale (DSS).
- The previous DSS ranged from 0 (normal) to 10 (death due to MS), with limited granularity in assessing disability progression.
Purpose of the Study:
- To introduce and describe a novel Expanded Disability Status Scale (EDSS) for more precise measurement of neurologic impairment in MS.
- To enhance the existing DSS by incorporating finer gradations and revised functional system assessments.
Main Methods:
- The new EDSS divides each previous integer step (1-9) into two half-steps (e.g., 1.0, 1.5, 2.0...9.5).
- Assessment within the EDSS is now obligatorily defined by grades from specific Functional Systems (FS).
- Revisions were made to the Sensory and Bowel & Bladder FS, and all 8 FS (Pyramidal, Cerebellar, Brain Stem, Sensory, Bowel & Bladder, Visual, Cerebral, Other) were analyzed in relation to the EDSS.
Main Results:
- The revised EDSS provides a more detailed and nuanced scale for quantifying disability in MS.
- Demonstration of patterns in FS grades and their relationship to the new EDSS steps.
- The revised FS components offer improved assessment capabilities for specific MS-related deficits.
Conclusions:
- The Expanded Disability Status Scale offers a significant improvement in the detailed assessment of neurologic disability in Multiple Sclerosis.
- The refined scale and revised functional systems provide a more accurate representation of disease status and progression.
- This enhanced scale facilitates more precise clinical evaluations and research in MS management.